Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00113685 · ClinicalTrials.gov registry record · NA
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT00113685 is a NA study that has completed, run by University of Washington. The registered enrollment target is 209 participants.
The verdict
NCT00113685, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
Interventions
- DRUG Lactated Ringer's Solution
- DRUG Hypertonic Saline-Dextran Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00113685
The ClinicalTrials.gov registry entry for NCT00113685 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lactated Ringer's Solution is the first listed.
NCT00113685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00113685 about?
NCT00113685 is a clinical study titled "Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury". The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with b...
What is the current status of trial NCT00113685?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2003-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00113685?
The interventions under investigation include: Lactated Ringer's Solution (DRUG), Hypertonic Saline-Dextran Solution (DRUG).
Who is sponsoring clinical trial NCT00113685?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.